勘误：异质性核糖核蛋白A1表达及炎症指标对手术切除肝细胞癌患者的预后价值：来自中国肝细胞癌高发地区的观点
Erratum: Prognostic value of heterogeneous ribonucleoprotein A1 expression and inflammatory indicators for patients with surgically resected hepatocellular carcinoma: Perspectives from a high occurrence area of hepatocellular carcinoma in China.
作者信息
Ke Ruisheng, Lv Lizhi, Li Jiayan, Zhang Xiaojin, Yang Fang, Zhang Kun, Jiang Yi
出版信息
Oncol Lett. 2019 Jan;17(1):718. doi: 10.3892/ol.2018.9580. Epub 2018 Oct 15.
Abstract
[This corrects the article DOI: 10.3892/ol.2018.9079.].
摘要
[本文更正文章DOI：10.3892/ol.2018.9079。]
相似文献
1
Erratum: Prognostic value of heterogeneous ribonucleoprotein A1 expression and inflammatory indicators for patients with surgically resected hepatocellular carcinoma: Perspectives from a high occurrence area of hepatocellular carcinoma in China.勘误：异质性核糖核蛋白A1表达及炎症指标对手术切除肝细胞癌患者的预后价值：来自中国肝细胞癌高发地区的观点
Oncol Lett. 2019 Jan;17(1):718. doi: 10.3892/ol.2018.9580. Epub 2018 Oct 15.
2
Prognostic value of heterogeneous ribonucleoprotein A1 expression and inflammatory indicators for patients with surgically resected hepatocellular carcinoma: Perspectives from a high occurrence area of hepatocellular carcinoma in China.异质性核糖核蛋白A1表达及炎症指标对手术切除肝细胞癌患者的预后价值：来自中国肝细胞癌高发地区的观点
Oncol Lett. 2018 Sep;16(3):3746-3756. doi: 10.3892/ol.2018.9079. Epub 2018 Jul 4.
3
Prognostic Value of Ki67 Expression for Patients with Surgically Resected Hepatocellular Carcinoma: Perspectives from a High Incidence Area.Ki67表达对手术切除肝细胞癌患者的预后价值：来自高发病率地区的观点
Clin Lab. 2017 Feb 1;63(2):355-364. doi: 10.7754/Clin.Lab.2016.160638.
4
Prognostic value and oncogene function of heterogeneous nuclear ribonucleoprotein A1 overexpression in HBV-related hepatocellular carcinoma.异质性核核糖核蛋白 A1 过表达在乙型肝炎病毒相关性肝细胞癌中的预后价值和癌基因功能。
Int J Biol Macromol. 2019 May 15;129:140-151. doi: 10.1016/j.ijbiomac.2019.02.012. Epub 2019 Feb 4.
5
Heterogeneous nuclear ribonucleoprotein A2/B1 in association with hTERT is a potential biomarker for hepatocellular carcinoma.异质核核糖核蛋白 A2/B1 与端粒酶逆转录酶结合是肝细胞癌的潜在生物标志物。
Liver Int. 2012 Aug;32(7):1146-55. doi: 10.1111/j.1478-3231.2012.02778.x. Epub 2012 Feb 28.
6
Erratum: Expression of and gene regulation network in hepatocellular carcinoma.勘误：肝细胞癌中[未提及的相关内容]的表达及基因调控网络。 （备注：原文中“Expression of and”表述不完整，推测可能是有信息缺失）
Oncol Lett. 2020 Nov;20(5):135. doi: 10.3892/ol.2020.11996. Epub 2020 Aug 20.
7
Erratum: High TNF-α and/or p38MAPK expression predicts a favourable prognosis in patients with T1N0M0 hepatocellular carcinoma: An immunohistochemical study.勘误：高肿瘤坏死因子-α（TNF-α）和/或p38丝裂原活化蛋白激酶（p38MAPK）表达预示T1N0M0期肝细胞癌患者预后良好：一项免疫组织化学研究。
Oncol Lett. 2019 Oct;18(4):4357-4359. doi: 10.3892/ol.2019.10781. Epub 2019 Aug 23.
8
Erratum: HBV suppresses thapsigargin-induced apoptosis via inhibiting CHOP expression in hepatocellular carcinoma cells.勘误：乙肝病毒通过抑制肝癌细胞中CHOP的表达来抑制毒胡萝卜素诱导的细胞凋亡。
Oncol Lett. 2017 Dec;14(6):8227. doi: 10.3892/ol.2017.7243. Epub 2017 Oct 20.
9
Overexpression of HnRNP A1 promotes tumor invasion through regulating CD44v6 and indicates poor prognosis for hepatocellular carcinoma.HnRNP A1 的过表达通过调节 CD44v6 促进肿瘤侵袭，并预示着肝细胞癌的预后不良。
Int J Cancer. 2013 Mar 1;132(5):1080-9. doi: 10.1002/ijc.27742. Epub 2012 Aug 7.
10
Erratum: miR-185 inhibits cell migration and invasion of hepatocellular carcinoma through CDC42.勘误：miR-185通过CDC42抑制肝细胞癌的细胞迁移和侵袭。
Oncol Lett. 2020 Jan;19(1):1089. doi: 10.3892/ol.2019.11186. Epub 2019 Dec 4.
Zotero 插件